secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001104659-24-102775
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Mark S. Blumenkranz resigns from KALA BIO board immediately
--------------------------------------------------------------------

- Mark S. Blumenkranz, M.D. resigned from the Board of Directors effective September 23, 2024.
- He also stepped down from the Audit Committee and Nominating and Corporate Governance Committee.
- Resignation was not related to any disagreement with the company's operations, policies, or practices.
- No replacement director has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000110465924102775/0001104659-24-102775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000110465924102775/tm2424692d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-102775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer